Head and Neck Cancer Trial, Recruiting NCT06182657 Sponsor: Jiangxi Provincial Cancer Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06182657
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to give your consent to take part in the study
  • You are over 18 years old
  • You are generally well enough to carry out daily activities with little or no limitation (this is measured using a standard scale — confirm with trial site)
  • Your cancer has been confirmed by a tissue sample as nasopharyngeal cancer (a type of cancer at the back of the nose and throat), regardless of a specific test result called EBER
  • Your cancer is at an advanced local stage (stage III or stage IVa), meaning it has grown or spread to nearby areas but not to distant parts of the body
  • You are willing and able to attend all required appointments, treatments, and follow-up visits for the full length of the study

Who may not be able to join:

  • You are currently taking part in another clinical trial that involves a treatment or intervention (being in an observational study or a follow-up phase of a previous study may be acceptable — confirm with trial site)
  • Your cancer has already spread to distant parts of your body (such as other organs or bones)
  • You have already received any cancer treatment for this nasopharyngeal cancer, such as chemotherapy, immunotherapy, radiotherapy, or similar therapies
  • You have a history of another type of cancer
  • You are currently pregnant
  • You have a known allergy or sensitivity to any medicines
  • The trial doctor feels, for any reason, that taking part would not be suitable or safe for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jingao Li, PhD, Jiangxi Provincial Cancer Hospital

Phone: 8613970866296

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jiangxi Provincial Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progress-free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov